tiprankstipranks
CVS Health Corp (CVS)
NYSE:CVS
US Market
CVS
CVS Health
RESEARCH TOOLSreports
Want to see CVS full AI Analyst Report?

CVS Health (CVS) Ratios

14,367 Followers

CVS Health Ratios

CVS's free cash flow for Q1 2026 was $0.16. For the 2026 fiscal year, CVS's free cash flow was decreased by $ and operating cash flow was $0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.87 0.84 0.81 0.86 0.95
Quick Ratio
 0.66 0.63 0.60 0.63 0.67
Cash Ratio
 0.11 0.10 0.10 0.10 0.19
Solvency Ratio
 0.04 0.03 0.05 0.07 0.05
Operating Cash Flow Ratio
 0.12 0.12 0.11 0.17 0.23
Short-Term Operating Cash Flow Coverage
 4.00 1.83 1.59 4.52 9.10
Net Current Asset Value
$ -100.52B$ -110.97B$ -108.84B$ -105.23B$ -90.87B
Leverage Ratios
Debt-to-Assets Ratio
 0.31 0.36 0.33 0.32 0.31
Debt-to-Equity Ratio
 1.01 1.24 1.10 1.04 0.99
Debt-to-Capital Ratio
 0.50 0.55 0.52 0.51 0.50
Long-Term Debt-to-Capital Ratio
 0.44 0.49 0.44 0.43 0.41
Financial Leverage Ratio
 3.27 3.47 3.35 3.27 3.19
Debt Service Coverage Ratio
 1.86 1.06 1.39 2.73 2.67
Interest Coverage Ratio
 1.92 3.33 2.88 5.17 3.48
Debt to Market Cap
 0.52 0.78 1.17 0.61 0.43
Interest Debt Per Share
 63.99 76.33 68.21 63.85 55.65
Net Debt to EBITDA
 6.18 8.63 5.43 3.91 4.68
Profitability Margins
Gross Profit Margin
13.87%13.77%13.79%15.21%16.90%
EBIT Margin
1.61%1.31%2.44%3.87%2.52%
EBITDA Margin
2.73%2.45%3.67%5.09%3.83%
Operating Profit Margin
1.46%2.58%2.28%3.84%2.47%
Pretax Profit Margin
0.85%0.53%1.65%3.12%1.81%
Net Profit Margin
0.72%0.44%1.24%2.33%1.34%
Continuous Operations Profit Margin
0.71%0.43%1.23%2.34%1.34%
Net Income Per EBT
84.81%82.77%75.05%74.68%73.87%
EBT Per EBIT
57.95%20.57%72.19%81.30%73.37%
Return on Assets (ROA)
1.16%0.68%1.82%3.34%1.89%
Return on Equity (ROE)
3.87%2.35%6.11%10.91%6.03%
Return on Capital Employed (ROCE)
3.58%6.02%5.05%8.06%5.01%
Return on Invested Capital (ROIC)
2.91%4.72%3.61%5.87%3.63%
Return on Tangible Assets
2.06%1.18%3.43%6.46%3.44%
Earnings Yield
2.53%1.76%8.16%8.22%3.53%
Efficiency Ratios
Receivables Turnover
 9.95 10.11 10.22 10.16 11.82
Payables Turnover
 20.76 5.84 20.22 20.36 18.06
Inventory Turnover
 19.77 18.01 17.75 16.83 14.04
Fixed Asset Turnover
 14.68 14.33 12.88 11.76 10.49
Asset Turnover
 1.61 1.54 1.47 1.43 1.41
Working Capital Turnover Ratio
 -31.91 -26.86 -27.32 -47.33 -55.66
Cash Conversion Cycle
 37.56 -6.14 38.22 39.70 36.67
Days of Sales Outstanding
 36.68 36.11 35.71 35.94 30.87
Days of Inventory Outstanding
 18.46 20.26 20.56 21.69 26.00
Days of Payables Outstanding
 17.58 62.52 18.05 17.92 20.21
Operating Cycle
 55.14 56.37 56.27 57.63 56.88
Cash Flow Ratios
Operating Cash Flow Per Share
 8.12 8.40 7.23 10.45 12.33
Free Cash Flow Per Share
 5.81 6.16 5.02 8.09 10.25
CapEx Per Share
 2.31 2.24 2.21 2.36 2.08
Free Cash Flow to Operating Cash Flow
 0.72 0.73 0.69 0.77 0.83
Dividend Paid and CapEx Coverage Ratio
 1.63 1.71 1.48 2.18 2.87
Capital Expenditure Coverage Ratio
 3.52 3.76 3.27 4.43 5.93
Operating Cash Flow Coverage Ratio
 0.13 0.11 0.11 0.17 0.23
Operating Cash Flow to Sales Ratio
 0.03 0.03 0.02 0.04 0.05
Free Cash Flow Yield
6.37%7.76%11.19%10.25%11.00%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 41.65 56.87 12.25 12.16 28.36
Price-to-Sales (P/S) Ratio
 0.30 0.25 0.15 0.28 0.38
Price-to-Book (P/B) Ratio
 1.58 1.34 0.75 1.33 1.71
Price-to-Free Cash Flow (P/FCF) Ratio
 16.55 12.88 8.93 9.76 9.09
Price-to-Operating Cash Flow Ratio
 11.82 9.45 6.21 7.56 7.56
Price-to-Earnings Growth (PEG) Ratio
 -0.93 -0.92 -0.28 0.13 -0.63
Price-to-Fair Value
 1.58 1.34 0.75 1.33 1.71
Enterprise Value Multiple
 17.18 18.82 9.56 9.49 14.58
Enterprise Value
 184.89B 185.63B 130.85B 172.65B 180.05B
EV to EBITDA
 16.61 18.82 9.56 9.49 14.58
EV to Sales
 0.45 0.46 0.35 0.48 0.56
EV to Free Cash Flow
 25.00 23.78 20.68 16.61 13.39
EV to Operating Cash Flow
 17.89 17.45 14.37 12.86 11.13
Tangible Book Value Per Share
 -25.85 -28.10 -34.05 -34.14 -23.77
Shareholders’ Equity Per Share
 60.85 59.36 60.02 59.50 54.47
Tax and Other Ratios
Effective Tax Rate
 0.16 0.19 0.25 0.25 0.26
Revenue Per Share
 320.43 317.34 296.12 278.42 245.78
Net Income Per Share
 2.30 1.40 3.66 6.49 3.29
Tax Burden
 0.85 0.83 0.75 0.75 0.74
Interest Burden
 0.53 0.41 0.68 0.81 0.72
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.11 0.00 0.00
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 2.51 6.16 1.99 1.60 3.74
Currency in USD